Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

4,700

Employees4,700

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

4,700

Employees4,700

MRNA Key Statistics

Market cap

21.15B

Market cap21.15B

Price-Earnings ratio

-7.37

Price-Earnings ratio-7.37

Dividend yield

—

Dividend yield—

Average volume

6.98M

Average volume6.98M

High today

$54.24

High today$54.24

Low today

$51.65

Low today$51.65

Open price

$52.57

Open price$52.57

Volume

4.47M

Volume4.47M

52 Week high

$59.55

52 Week high$59.55

52 Week low

$22.28

52 Week low$22.28

Stock Snapshot

The current Moderna(MRNA) stock price is $53.59, with a market capitalization of 21.15B. The stock trades at a price-to-earnings (P/E) ratio of -7.37.

On 2026-03-25, Moderna(MRNA) stock moved within a range of $51.65 to $54.24. With shares now at $53.59, the stock is trading +3.8% above its intraday low and -1.2% below the session's peak.

Trading volume for Moderna(MRNA) stock has reached 4.47M, versus its average volume of 6.98M.

The stock's 52-week range extends from a low of $22.28 to a high of $59.55.

MRNA News

Nasdaq 8h

Moderna Stock is Soaring. Is It Too Late to Buy?

Key Points Moderna’s first big success was its coronavirus vaccine -- that product brought in $18 billion in revenue at its peak. The biotech recently submitt...

Simply Wall St 2d

Assessing Whether Moderna Is Undervalued As Growth Plans Face Profitability Test

Advertisement Moderna’s recent performance snapshot Moderna (MRNA) has drawn attention after a period of mixed returns, with the stock showing a loss over the...

Nasdaq 6d

Pfizer vs Moderna: Which Pharma Stock Has More Upside?

Key Points The smaller, more volatile of these two companies has higher potential for significant gains. However, that also comes with a healthy dose of risk....

Analyst ratings

73%

of 26 ratings

Buy

11.5%

Hold

73.1%

Sell

15.4%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.